{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T16:55:32Z","timestamp":1774976132319,"version":"3.50.1"},"reference-count":25,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2020,7,30]]},"DOI":"10.1536\/ihj.20-099","type":"journal-article","created":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T22:05:34Z","timestamp":1596060334000},"page":"705-712","source":"Crossref","is-referenced-by-count":16,"title":["Elevated Homocysteine Levels Associated with Atrial Fibrillation and Recurrent Atrial Fibrillation"],"prefix":"10.1536","volume":"61","author":[{"given":"Hao","family":"Rong","sequence":"first","affiliation":[{"name":"Department of Cardiology, Ningbo Hangzhou Bay Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Ningbo Hangzhou Bay Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nake","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Ningbo Hangzhou Bay Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Hong","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Ningbo Hangzhou Bay Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianan","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Ningbo Hangzhou Bay Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanshan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Ningbo Hangzhou Bay Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuquan","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Pu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Finkelstein JD, Martin JJ. Homocysteine. Int J Biochem Cell Biol 2000; 32: 385-9.","DOI":"10.1016\/S1357-2725(99)00138-7"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. May HT, Alharethi R, Anderson JL, <i>et al<\/i>. Homocysteine levels are associated with increased risk of congestive heart failure in patients with and without coronary artery disease. Cardiology 2007; 107: 178-84.","DOI":"10.1159\/000095344"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Vizzardi E, Bonadei I, Zanini G, <i>et al<\/i>. Homocysteine and heart failure: an overview. Recent Pat Cardiovasc Drug Discov 2009; 4: 15-21.","DOI":"10.2174\/157489009787259991"},{"key":"4","unstructured":"4. Gutierrez C, Blanchard DG. Diagnosis and treatment of atrial fibrillation. Am Fam Physician 2016; 94: 442-52."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Cingozbay BY, Yiginer O, Cebeci BS, Kardesoglu E, Demiralp E, Dincturk M. Role of homocysteine for thromboembolic complication in patients with non-valvular atrial fibrilation. Blood Coagul Fibrinolysis 2002; 13: 609-13.","DOI":"10.1097\/00001721-200210000-00005"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Shi D, Meng Q, Zhou X, <i>et al<\/i>. Factors influencing the relationship between atrial fibrillation and artery stiffness in elderly chinese patients with hypertension. Aging Clin Exp Res 2016; 28: 653-8.","DOI":"10.1007\/s40520-015-0455-8"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Schnabel RB, Larson MG, Yamamoto JF, <i>et al<\/i>. Relations of biomarkers of distinct pathophysiological pathways and atrial fibrillation incidence in the community. Circulation 2010; 121: 200-7.","DOI":"10.1161\/CIRCULATIONAHA.109.882241"},{"key":"8","unstructured":"8. Huang L, Shen R, Huang L, Yu J, Rong H. Association between serum copper and heart failure: a meta-analysis. Asia Pac J Clin Nutr 2019; 28: 761-9."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Zhang Z, Yang Y, Ng CY, <i>et al<\/i>. Meta-analysis of vitamin d deficiency and risk of atrial fibrillation. Clin Cardiol 2016; 39: 537-43.","DOI":"10.1002\/clc.22563"},{"key":"10","unstructured":"10. Marcucci R, Betti I, Cecchi E, <i>et al<\/i>. Hyperhomocysteinemia and vitamin b6 deficiency: New risk markers for nonvalvular atrial fibrillation? Am Heart J 2004; 148: 456-61."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Giusti B, Gori AM, Marcucci R, <i>et al<\/i>. Role of c677t and a1298c mthfr, a2756g mtr and -786 c\/t enos gene polymorphisms in atrial fibrillation susceptibility. PLoS One 2007; 2: e495.","DOI":"10.1371\/journal.pone.0000495"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12. Shimano M, Inden Y, Tsuji Y, <i>et al<\/i>. Circulating homocysteine levels in patients with radiofrequency catheter ablation for atrial fibrillation. Europace 2008; 10: 961-6.","DOI":"10.1093\/europace\/eun140"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Naji F, Suran D, Kanic V, Vokac D, Sabovic M. High homocysteine levels predict the recurrence of atrial fibrillation after successful electrical cardioversion. Int Heart J 2010; 51: 30-3.","DOI":"10.1536\/ihj.51.30"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Nasso G, Bonifazi R, Romano V, <i>et al<\/i>. Increased plasma homocysteine predicts arrhythmia recurrence after minimally invasive epicardial ablation for nonvalvular atrial fibrillation. J Thorac Cardiovasc Surg 2013; 146: 848-53.","DOI":"10.1016\/j.jtcvs.2012.07.099"},{"key":"15","unstructured":"15. Yao Y, Gao LJ, Zhou Y, <i>et al<\/i>. Effect of advanced age on plasma homocysteine levels and its association with ischemic stroke in non-valvular atrial fibrillation. J Geriatr Cardiol 2017; 14: 743-9."},{"key":"16","first-page":"66","volume":"19","year":"2017","unstructured":"16. Yao Y, Yao W, Bai R, <i>et al<\/i>. Plasma homocysteine levels predict early recurrence after catheter ablation of persistent atrial fibrillation. Europace 2017; 19: 66-71.","journal-title":"Europace","ISSN":"https:\/\/id.crossref.org\/issn\/1099-5129","issn-type":"print"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Kubota Y, Alonso A, Heckbert SR, Norby FL, Folsom AR. Homocysteine and incident atrial fibrillation: The atherosclerosis risk in communities study and the multi-ethnic study of atherosclerosis. Heart Lung Circ 2019; 28: 615-22.","DOI":"10.1016\/j.hlc.2018.03.007"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Joseph J, Joseph L, Shekhawat NS, <i>et al<\/i>. Hyperhomocysteinemia leads to pathological ventricular hypertrophy in normotensive rats. Am J Physiol Heart Circ Physiol 2003; 285: H679-86.","DOI":"10.1152\/ajpheart.00145.2003"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Miller A, Mujumdar V, Palmer L, Bower JD, Tyagi SC. Reversal of endocardial endothelial dysfunction by folic acid in homocysteinemic hypertensive rats. Am J Hypertens 2002; 15: 157-63.","DOI":"10.1016\/S0895-7061(01)02286-5"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Cai BZ, Gong DM, Liu Y, <i>et al<\/i>. Homocysteine inhibits potassium channels in human atrial myocytes. Clin Exp Pharmacol Physiol 2007; 34: 851-5.","DOI":"10.1111\/j.1440-1681.2007.04671.x"},{"key":"21","doi-asserted-by":"publisher","unstructured":"21. Cai B, Shan L, Gong D, <i>et al<\/i>. Homocysteine modulates sodium channel currents in human atrial myocytes. Toxicology 2009; 256: 201-6.","DOI":"10.1016\/j.tox.2008.11.020"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Law P, Kharche S, Stott J, Zhang H. Effects of elevated homocysteine hormone on electrical activity in the human atrium: a simulation study. Conf Proc IEEE Eng Med Biol Soc 2009; 2009: 3936-9.","DOI":"10.1109\/IEMBS.2009.5333530"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Yao Y, Shang MS, Dong JZ, Ma CS. Homocysteine in non-valvular atrial fibrillation: Role and clinical implications. Clin Chim Acta 2017; 475: 85-90.","DOI":"10.1016\/j.cca.2017.10.012"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Wolff A, Shantsila E, Lip GY, Lane DA. Impact of advanced age on management and prognosis in atrial fibrillation: Insights from a population-based study in general practice. Age Ageing 2015; 44: 874-8.","DOI":"10.1093\/ageing\/afv071"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Taskin G, Yilmaz Sipahi E, Yildirimkaya M, <i>et al<\/i>. Plasma total homocysteine levels in a healthy turkish population sample. Acta Cardiol 2006; 61: 35-42.","DOI":"10.2143\/AC.61.1.2005138"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/61\/4\/61_20-099\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T03:51:45Z","timestamp":1596253905000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/61\/4\/61_20-099\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,30]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.20-099","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,30]]}}}